A Fas-associated Death Domain Protein-dependent Mechanism Mediates the Apoptotic Action of Non-steroidal Anti-inflammatory Drugs in the Human Leukemic Jurkat Cell Line*

Non-steroidalanti-inflammatory drugs (NSAIDs) are inhibitors of cyclooxygenase-1 and -2 and are useful for prevention and cure of cancers, especially colon and rectal cancers. The NSAIDs indomethacin and sulindac sulfide have been shown to induce apoptosis of colon epithelial cancer cells by a Bax-dependent mechanism that involves mitochondria-mediated activation of a caspase-9-dependent pathway. In this report, we demonstrate that indomethacin and sulindac sulfide induce apoptosis of human leukemic Jurkat cells by a mechanism that requires the Fas-associated Death Domain Protein-mediated activation of a caspase-8-dependent pathway. Therefore, NSAIDs induce apoptosis by different mechanisms depending on the cell type.

[1]  K. Kinzler,et al.  Role of BAX in the apoptotic response to anticancer agents. , 2000, Science.

[2]  P. Krammer,et al.  CD95's deadly mission in the immune system , 2000, Nature.

[3]  M. Hengartner.  The biochemistry of apoptosis , 2000, Nature.

[4]  A. Winoto,et al.  FADD Is Required for DR4- and DR5-mediated Apoptosis , 2000, The Journal of Biological Chemistry.

[5]  A. Bauer,et al.  Apoptosis-induced Cleavage of β-Catenin by Caspase-3 Results in Proteolytic Fragments with Reduced Transactivation Potential* , 2000, The Journal of Biological Chemistry.

[6]  J. Houghton,et al.  Fas-dependent and -independent mechanisms of cell death following DNA damage in human colon carcinoma cells. , 2000, Cancer research.

[7]  Xiaodong Wang,et al.  Cytochrome c Deficiency Causes Embryonic Lethality and Attenuates Stress-Induced Apoptosis , 2000, Cell.

[8]  R. Flavell,et al.  Divinations and surprises: genetic analysis of caspase function in mice. , 2000, Experimental cell research.

[9]  W. Earnshaw,et al.  Induction of apoptosis by cancer chemotherapy. , 2000, Experimental cell research.

[10]  G. Kroemer,et al.  The mitochondrion in cell death control: certainties and incognita. , 2000, Experimental cell research.

[11]  M. Hull,et al.  The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. , 2000, European journal of cancer.

[12]  J. Blenis,et al.  FADD is required for multiple signaling events downstream of the receptor Fas. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[13]  R. Langenbach,et al.  Malignant Transformation and Antineoplastic Actions of Nonsteroidal Antiinflammatory Drugs (Nsaids) on Cyclooxygenase-Null Embryo Fibroblasts , 1999, The Journal of experimental medicine.

[14]  D. Green,et al.  Suicidal Tendencies: Apoptotic Cell Death by Caspase Family Proteinases* , 1999, The Journal of Biological Chemistry.

[15]  E. Solary,et al.  Fas Ligand-independent, FADD-mediated Activation of the Fas Death Pathway by Anticancer Drugs* , 1999, The Journal of Biological Chemistry.

[16]  D. Tang,et al.  Cycloheximide-induced T-cell Death Is Mediated by a Fas-associated Death Domain-dependent Mechanism* , 1999, The Journal of Biological Chemistry.

[17]  J. Blenis,et al.  Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade , 1998, Current Biology.

[18]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[19]  Keisuke Kuida,et al.  Reduced Apoptosis and Cytochrome c–Mediated Caspase Activation in Mice Lacking Caspase 9 , 1998, Cell.

[20]  José Luis de la Pompa,et al.  Differential Requirement for Caspase 9 in Apoptotic Pathways In Vivo , 1998, Cell.

[21]  R. Jemmerson,et al.  A cytosolic factor is required for mitochondrial cytochrome c efflux during apoptosis , 1998, Cell Death and Differentiation.

[22]  D. Goeddel,et al.  FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. , 1998, Science.

[23]  N. Kabra,et al.  Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1 , 1998, Nature.

[24]  P. Scheurich,et al.  Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction , 1998, Current Biology.

[25]  W I Wood,et al.  Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. , 1997, Science.

[26]  Arul M. Chinnaiyan,et al.  The Receptor for the Cytotoxic Ligand TRAIL , 1997, Science.

[27]  William L. Smith,et al.  Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2* , 1996, The Journal of Biological Chemistry.

[28]  Bruno C. Hancock,et al.  Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.

[29]  Zhiyong Han,et al.  DNA-dependent Protein Kinase Is a Target for a CPP32-like Apoptotic Protease* , 1996, The Journal of Biological Chemistry.

[30]  C. J. Barnes,et al.  Aspirin suppresses 1,2‐dimethylhydrazine‐induced alteration of proliferative parameters in rat colonic crypts , 1996, Cell proliferation.

[31]  K. Bauer,et al.  Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA , 1996, Current Biology.

[32]  B. Rigas,et al.  Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. , 1995, Biochimica et biophysica acta.

[33]  W C Willett,et al.  Aspirin and the risk of colorectal cancer in women. , 1995, The New England journal of medicine.

[34]  M. Kondo,et al.  Expression of cyclooxygenase-1 and -2 in human colorectal cancer. , 1995, Cancer research.

[35]  B. Rigas,et al.  Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. , 1995, The Journal of clinical investigation.

[36]  Arul M. Chinnaiyan,et al.  FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.

[37]  J. Camonis,et al.  A Novel Protein That Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domain (*) , 1995, The Journal of Biological Chemistry.

[38]  R. Coffey,et al.  Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.

[39]  G. Thomas,et al.  Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2. , 1994, Gut.

[40]  C. Thiemermann,et al.  Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[41]  N. Davidson,et al.  Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. , 1993, Cancer research.

[42]  D. Dewitt,et al.  Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. , 1993, The Journal of biological chemistry.

[43]  R. Garavito,et al.  Cyclooxygenases: structural, cellular, and molecular biology. , 2000, Annual review of biochemistry.

[44]  S H Kaufmann,et al.  Mammalian caspases: structure, activation, substrates, and functions during apoptosis. , 1999, Annual review of biochemistry.

[45]  J. Case,et al.  In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. , 1992, The Journal of clinical investigation.